Goto, Ryoji
Matsuoka, Kiwamu
Kimura, Yasuyuki
Kataoka, Yuko
Oya, Masaki
Hirata, Kosei
Tagai, Kenji
Takahata, Keisuke
Seki, Chie
Kawamura, Kazunori
Zhang, Ming-Rong
Higuchi, Makoto
Endo, Hironobu
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21wm0425015, JP24wm0625001)
Article History
Received: 30 October 2024
Accepted: 7 March 2025
First Online: 13 March 2025
Declarations
:
: Ming-Rong Zhang and Makoto Higuchi are inventors of a patent application in relation to the imaging agents documented in this report, 18F-SPAL-T-06 (PCT/JP2021/30899) and 18F-C05-05 (2019-034997, PCT/JP2020/002607). All other authors have no conflicts of interest to declare.
: This study was approved by the Institutional Review Board of the National Institutes for Quantum Science and Technology and was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. The studies were registered with the Japan Registry for Clinical Trials (jRCTs031210180 and jRCTs031220123).
: All images are entirely unidentifiable and there are no details on the individuals reported.
: Written informed consent was obtained from all participants or their caregivers.